S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC episode artwork

EPISODE · Mar 1, 2024 · 19 MIN

S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

from Treating Together · host Targeted Oncology

In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy. 

Episode metadata supplied by the publisher feed · Published Mar 1, 2024

Embed this episode

Ready to play

S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

0:00 19:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Treating Together?

This episode is 19 minutes long.

When was this Treating Together episode published?

This episode was published on March 1, 2024.

Can I download this Treating Together episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!